FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158306178> ?p ?o ?g. }

• W2158306178 endingPage "94" @default.
• W2158306178 startingPage "2288" @default.
• W2158306178 abstract "2'-deoxy-2'-methylidenecytidine (DMDC) is a potent deoxycytidine analogue. Preclinical studies of DMDC demonstrated activity against a variety of murine and human tumors in cell cultures and murine models and indicate enhanced antitumor activity of DMDC when it was administered in a manner that provided prolonged systemic exposure. In view of this observation, this study was designed to determine the toxicities, maximum-tolerated dose, and pharmacokinetic profile of DMDC. DMDC was given p.o. under fasting conditions for 14 consecutive days every 4 weeks in patients with advanced solid tumors. The starting dose was 12 mg/m2/day. Pharmacokinetic studies were carried out on days 1 and 14 of the first cycle. Fourteen patients received 22 courses of DMDC. The dose-limiting toxicities were anorexia, leukopenia, thrombocytopenia, and anemia. General fatigue was the common nonhematological toxicity. The maximum-tolerated dose was 18 mg/m2/day, at which two of six patients developed grade 3 toxicities. This dose level could also be considered for Phase II testing with this schedule. At the 18-mg/m2/day dose level, the mean terminal half-life, maximum plasma concentration (Cmax), the area under the plasma drug concentration-time curve (AUC(0-infinity)) on day 1 were 1.7496 h, 112.9 ng/ml, and 399.8 ng x h/ml, respectively. Forty to 50% of the administered dose was recovered in the urine, indicating a good bioavailability and resulting significant systemic exposure to the drug, which may enable chronic oral treatment." @default.
• W2158306178 created "2016-06-24" @default.
• W2158306178 creator A5002461553 @default.
• W2158306178 creator A5004024254 @default.
• W2158306178 creator A5008243490 @default.
• W2158306178 creator A5012789660 @default.
• W2158306178 creator A5017396574 @default.
• W2158306178 creator A5023792530 @default.
• W2158306178 creator A5024261346 @default.
• W2158306178 creator A5031751285 @default.
• W2158306178 creator A5032337115 @default.
• W2158306178 creator A5040839997 @default.
• W2158306178 creator A5050397674 @default.
• W2158306178 creator A5063527387 @default.
• W2158306178 creator A5065531912 @default.
• W2158306178 creator A5070103054 @default.
• W2158306178 creator A5074857320 @default.
• W2158306178 creator A5089962381 @default.
• W2158306178 date "2000-06-01" @default.
• W2158306178 modified "2023-10-03" @default.
• W2158306178 title "Phase I trial of oral 2'-deoxy-2'-methylidenecytidine: on a daily x 14-day schedule." @default.
• W2158306178 cites W1577909961 @default.
• W2158306178 cites W1626199312 @default.
• W2158306178 cites W1831623534 @default.
• W2158306178 cites W1857358013 @default.
• W2158306178 cites W1858072261 @default.
• W2158306178 cites W1890647543 @default.
• W2158306178 cites W1975549289 @default.
• W2158306178 cites W2012432138 @default.
• W2158306178 cites W2013403355 @default.
• W2158306178 cites W2021595217 @default.
• W2158306178 cites W2028269517 @default.
• W2158306178 cites W203548408 @default.
• W2158306178 cites W2066575491 @default.
• W2158306178 cites W2111702134 @default.
• W2158306178 cites W2346777243 @default.
• W2158306178 cites W2464426841 @default.
• W2158306178 cites W279066339 @default.
• W2158306178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10873079" @default.
• W2158306178 hasPublicationYear "2000" @default.
• W2158306178 type Work @default.
• W2158306178 sameAs 2158306178 @default.
• W2158306178 citedByCount "4" @default.
• W2158306178 countsByYear W21583061782020 @default.
• W2158306178 crossrefType "journal-article" @default.
• W2158306178 hasAuthorship W2158306178A5002461553 @default.
• W2158306178 hasAuthorship W2158306178A5004024254 @default.
• W2158306178 hasAuthorship W2158306178A5008243490 @default.
• W2158306178 hasAuthorship W2158306178A5012789660 @default.
• W2158306178 hasAuthorship W2158306178A5017396574 @default.
• W2158306178 hasAuthorship W2158306178A5023792530 @default.
• W2158306178 hasAuthorship W2158306178A5024261346 @default.
• W2158306178 hasAuthorship W2158306178A5031751285 @default.
• W2158306178 hasAuthorship W2158306178A5032337115 @default.
• W2158306178 hasAuthorship W2158306178A5040839997 @default.
• W2158306178 hasAuthorship W2158306178A5050397674 @default.
• W2158306178 hasAuthorship W2158306178A5063527387 @default.
• W2158306178 hasAuthorship W2158306178A5065531912 @default.
• W2158306178 hasAuthorship W2158306178A5070103054 @default.
• W2158306178 hasAuthorship W2158306178A5074857320 @default.
• W2158306178 hasAuthorship W2158306178A5089962381 @default.
• W2158306178 hasConcept C112705442 @default.
• W2158306178 hasConcept C126322002 @default.
• W2158306178 hasConcept C181389837 @default.
• W2158306178 hasConcept C22979827 @default.
• W2158306178 hasConcept C2780035454 @default.
• W2158306178 hasConcept C2780873365 @default.
• W2158306178 hasConcept C29730261 @default.
• W2158306178 hasConcept C71924100 @default.
• W2158306178 hasConcept C76318530 @default.
• W2158306178 hasConcept C98274493 @default.
• W2158306178 hasConceptScore W2158306178C112705442 @default.
• W2158306178 hasConceptScore W2158306178C126322002 @default.
• W2158306178 hasConceptScore W2158306178C181389837 @default.
• W2158306178 hasConceptScore W2158306178C22979827 @default.
• W2158306178 hasConceptScore W2158306178C2780035454 @default.
• W2158306178 hasConceptScore W2158306178C2780873365 @default.
• W2158306178 hasConceptScore W2158306178C29730261 @default.
• W2158306178 hasConceptScore W2158306178C71924100 @default.
• W2158306178 hasConceptScore W2158306178C76318530 @default.
• W2158306178 hasConceptScore W2158306178C98274493 @default.
• W2158306178 hasIssue "6" @default.
• W2158306178 hasLocation W21583061781 @default.
• W2158306178 hasOpenAccess W2158306178 @default.
• W2158306178 hasPrimaryLocation W21583061781 @default.
• W2158306178 hasRelatedWork W1752921906 @default.
• W2158306178 hasRelatedWork W1969876219 @default.
• W2158306178 hasRelatedWork W1999193084 @default.
• W2158306178 hasRelatedWork W2000173078 @default.
• W2158306178 hasRelatedWork W2035255429 @default.
• W2158306178 hasRelatedWork W2070990639 @default.
• W2158306178 hasRelatedWork W2073694890 @default.
• W2158306178 hasRelatedWork W2377078202 @default.
• W2158306178 hasRelatedWork W2605186162 @default.
• W2158306178 hasRelatedWork W3183375046 @default.
• W2158306178 hasVolume "6" @default.
• W2158306178 isParatext "false" @default.
• W2158306178 isRetracted "false" @default.

• next